Vnitr Lek 2026, 72(1):56-59

Interdisciplinary recommendations for thrombophilia testing

Eva Drbohlavová1,A, Jaromír Gumulec2,A, Alena Buliková3,A, Petr Dulíček4,A, Jana Hirmerová5,A,B, Radovan Malý6,A,B, Ester Zápotocká7,A, Jan Blatný8,A, Jan Václavík9,C, Petr Kessler10,D
1 Oddělení klinické hematologie Krajské nemocnice Liberec, a. s.
2 Klinika hematoonkologie Fakultní nemocnice Ostrava a Lékařské fakulty Ostravské univerzity
3 Oddělení klinické hematologie Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity v Brně
4 IV. interní hematologická klinika Fakultní nemocnice Hradec Králové
5 II. interní klinika Fakultní nemocnice Plzeň a Lékařské fakulty Univerzity Karlovy Plzeň
6 I. interní kardioangiologická klinika Fakultní nemocnice Hradec Králové
7 Klinika dětské hematologie a onkologie 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol, Praha
8 Oddělení dětské hematologie a biochemie FN Brno
9 Interní a kardiologická klinika Fakultní nemocnice Ostrava
10 Oddělení hematologie a transfuziologie Nemocnice Pelhřimov AČeská společnost pro trombózu a hemostázu ČLS JEP
A Česká společnost pro trombózu a hemostázu ČLS JEP
B Česká angiologická společnost ČLS JEP
C Česká internistická společnost ČLS JEP
D Česká hematologická společnost ČLS JEP

In this interdisciplinary consensus of four medical societies dealing with thrombophilic disorders, we summarize the rules of diagnosis and care of patients with congenital or acquired thrombophilias, i.e. factors increasing the risk of venous thromboembolic disease. The primary goal is to standardize the care of these patients with respect to the rules of evidence-based medicine. The recommendations imply under which circumstances, in which clinical situations, for which patients and which tests it is useful to investigate which thrombophilias and when not. Despite the long history and very good availability of diagnostic tests for individual thrombophilias, no similar recommendation has been published in the Czech Republic.

Keywords: congenital and acquired thrombophilias, venous thromboembolism, arterial thrombosis.

Published: February 12, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drbohlavová E, Gumulec J, Buliková A, Dulíček P, Hirmerová J, Malý R, et al.. Interdisciplinary recommendations for thrombophilia testing. Vnitr Lek. 2026;72(1):56-59.
Download citation

References

  1. Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 2023;7(22):7101-7138. Go to original source... Go to PubMed...
  2. Arachchillage DJ, Mackillop L, Chandratheva A, et al. Thrombophilia testing: A British Society for Haematology guideline. Br J Haematol. 2022 Aug;198(3):443-458. Go to original source... Go to PubMed...
  3. Parakh RS, Sabath DE. Venous Thromboembolism: Role of the Clinical Laboratory in Diagnosis and Management. J Appl Lab Med. 2019 Mar;3(5):870-882. Go to original source... Go to PubMed...
  4. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-220. Go to original source... Go to PubMed...
  5. Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA, et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: A single-center cross-sectional study. Thromb Res 2023;223:87-94. e-pub ahead of print 20221215; Go to original source... Go to PubMed...
  6. Quenby S, Booth K, Hiller L, et al. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Lancet. 2023;402(10395):54-61. e-pub ahead of print 20230601. Go to original source... Go to PubMed...
  7. Schulman S, Konstantinides S, Hu Y, Tang LV. Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158]. Thromb Haemost 2020; 120(8): 1143-1146. e-pub ahead of print 20200611. Go to original source... Go to PubMed...
  8. National Institute for Health and Care Excellence: Clinical Guidelines. In: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. National Institute for Health and Care Excellence (NICE) Copyright © NICE 2023.: London, 2023.
  9. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med 2017; 377(23): 2298. Go to original source... Go to PubMed...
  10. Nicolaides AN, Fareed J, Spyropoulos AC, et al. Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol. 2024;43(1):1-222. Go to original source... Go to PubMed...
  11. Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost. 2016;14(7):1480-1483. e-pub ahead of print 20160607. Go to original source... Go to PubMed...
  12. Lowe G, Wu O, van Hylckama Vlieg A. Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: Systematic review and meta-analysis. Thromb Res. 2023 Sep;229:31-39. Go to original source... Go to PubMed...
  13. Drbohlavová E, Gumulec J, Buliková A, et al. Interdisciplinární doporučení pro testování trombofilie. Transfuze Hematol dnes. 2025;31(2):132-136. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.